Find insight on European pharmaceutical sector corporate bonds, GSK and more in the latest Market Talks covering Health Care.

President Trump is readying plans for industry-specific tariffs to kick in alongside his country-by-country duties in two ...

President Trump and his administration have been studying new sectoral tariffs that could cover a broad part of the American ...

Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...

The pharmaceutical sector continues to stand out as a resilient and highly profitable corner of the market, even amid global ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

Tariffs and the uncertainty surrounding them emerged as the biggest policy issue coming out of the first six months of the new administration.

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

Pharma prepares for looming tariffs, as the US president signals a phased increase starting Aug. 1, but the official starting ...

W hen Donald Trump’s tariffs are mentioned, you might recall his “Liberation Day” duties on uninhabited islands, his on-again ...

Trump has again threatened the multibillion-dollar pharmaceutical sector with high tariffs unless they move production to the U.S.